OCM
TMDX icon

Osterweis Capital Management’s Transmedics TMDX Stock Holding History

Osterweis Capital Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-38,835
Closed -$6.1M – 206
2024
Q3 		$6.1M Sell
38,835
-17,905
-32% -$2.76M 0.31% 86
2024
Q2 		$8.55M Sell
56,740
-20,250
-26% -$2.43M 0.44% 65
2024
Q1 		$5.69M Buy
76,990
+12,425
+19% +$1.02M 0.33% 79
2023
Q4 		$5.1M Buy
64,565
+28,390
+78% +$1.71M 0.32% 78
2023
Q3 		$1.98M Sell
36,175
-8,040
-18% -$579K 0.15% 89
2023
Q2 		$3.71M Buy
+44,215
New +$3.38M 0.25% 85
2022
Q3 		– Sell
-32,915
Closed -$1.03M – 243
2022
Q2 		$1.03M Buy
+32,915
New +$878K 0.08% 107

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Osterweis Capital Management's TMDX Position: Q4 2024 in Review

Osterweis Capital Management sold out of Transmedics (TMDX) in Q4 2024, closing a stake of 38,835 shares — an estimated $6.1M sold.

Osterweis Capital Management first reported a position in TMDX in Q2 2022 and held it in 7 quarters. The position peaked at $8.55M in Q2 2024. 315 funds tracked by Wall St. Rank hold TMDX as of Q4 2024.

  • Osterweis Capital Management reported no remaining Transmedics position as of Q4 2024 after selling out during the quarter.
  • Osterweis Capital Management sold 38,835 Transmedics shares in Q4 2024, an estimated $6.1M.
  • Osterweis Capital Management first reported a position in Transmedics in Q2 2022 and held it in 7 quarters.
  • Osterweis Capital Management's Transmedics position peaked at $8.55M in Q2 2024.
  • 315 funds tracked by Wall St. Rank held Transmedics as of Q4 2024.

Based on Osterweis Capital Management's 13F filing for Q4 2024, filed 13 Feb 2025.